List of works - Paul Grootendorst

A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

scientific article

A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia

scientific article published on 01 July 2006

An empirical analysis of milk addiction.

scientific article published in November 2004

Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative study

scientific article

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.

scientific article published on 7 November 2011

Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study

article

Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments.

scientific article published on 10 July 2015

Does it matter whom and how you ask? inter- and intra-rater agreement in the Ontario Health Survey.

scientific article published in February 1997

Economic evaluation of vaccines in Canada: A systematic review

scientific article published on 18 February 2016

Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey

scientific article

Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries.

scientific article published on 12 August 2013

Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.

scientific article published on January 2004

Equity in dental care among Canadian households ⬇️

scientific article published on April 16, 2011

Estimating the clinical cost of drug development for orphan versus non-orphan drugs

scientific article published on 10 January 2019

Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator ⬇️

scientific article published on July 1, 1997

Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis.

scientific article

How Effective Is the Medicare Part D Drug Plan?

scientific article published on 01 June 2015

How should we support pharmaceutical innovation?

scientific article published on 01 August 2009

Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.

scientific article published in January 2006

Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study

scientific article published on 9 April 2018

Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario

scientific article published on 24 July 2018

Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature

scientific article published on 01 August 2009

Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.

scientific article published on 16 May 2015

Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy

scientific article published on 01 September 2000

The case for an essential medicines list for Canada

scientific article published on 13 June 2016

The cost of drug development: A systematic review ⬇️

scientific article published on January 21, 2011

The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.

scientific article published on September 2002

The impact of drug vintage on patient survival: a patient-level analysis using Quebec's provincial health plan data

scientific article

The opportunity cost of capital: development of new pharmaceuticals.

scientific article published in May 2015

Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip

scientific article published on 01 May 2008

List of works by Paul Grootendorst

A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia

An empirical analysis of milk addiction.

Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative study

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.

Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study

Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments.

Does it matter whom and how you ask? inter- and intra-rater agreement in the Ontario Health Survey.

Economic evaluation of vaccines in Canada: A systematic review

Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey

Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries.

Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.

Equity in dental care among Canadian households ⬇️

Estimating the clinical cost of drug development for orphan versus non-orphan drugs

Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator ⬇️

Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis.

How Effective Is the Medicare Part D Drug Plan?

How should we support pharmaceutical innovation?

Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.

Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study

Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario

Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature

Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.

Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy

The case for an essential medicines list for Canada

The cost of drug development: A systematic review ⬇️

The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.

The impact of drug vintage on patient survival: a patient-level analysis using Quebec's provincial health plan data

The opportunity cost of capital: development of new pharmaceuticals.

Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip